Literature DB >> 304779

Lymphocytotoxins in epileptic patients receiving phenytoin.

B S Ooi, K S Kant, I B Hanenson, A J Pesce, V E Pollak.   

Abstract

The present study was undertaken to determine the prevalence and nature of lymphocytotoxic antibodies in patients receiving phenytoin. Of forty-six sera examined, lymphocytotoxins and antinuclear antibodies were detected in fourteen and eleven samples respectively. Antibodies to double-stranded RNA (poly-A-poly-U) were found in six out of thirty-eight sera studied. A highly significant correlation was found between the presence of lymphocytotoxins and antinuclear antibodies (chi2 = 9.72; P less than 0.01). Lymphocytotoxins were found to be of the IgM class, to have activity against T and B cells, and to be dependent on the presence of Ca and Mg ions for activity. These findings may have pathogenetic importance in the genesis of the altered immune state of patients reveiving phenytoin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 304779      PMCID: PMC1541175     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  ANTINUCLEAR ANTIBODIES IN FAMILIES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  V E POLLAK
Journal:  N Engl J Med       Date:  1964-07-23       Impact factor: 91.245

2.  SYSTEMIC LUPUS ERYTHEMATOSUS IN CHILDHOOD. REPORT OF THIRTY-FIVE CASES, WITH DISCUSSION OF SEVEN APPARENTLY INDUCED BY ANTICONVULSANT MEDICATION, AND OF PROGNOSIS AND TREATMENT.

Authors:  J C JACOBS
Journal:  Pediatrics       Date:  1963-08       Impact factor: 7.124

3.  Lupus erythematosus disseminatus after administration of mesantoin; report of two cases.

Authors:  T LINDQVIST
Journal:  Acta Med Scand       Date:  1957-08-13

4.  Antinuclear antibodies in patients on anticonvulsant therapy.

Authors:  D Alarcón-Segovia; E Fishbein; P A Reyes; H Díes; S Shwadsky
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

5.  Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders.

Authors:  R C Williams; R B Lies; R P Messner
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

6.  Lymphocytotoxins in myasthenia gravis.

Authors:  W Knapp; K Pateisky
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1972-12

7.  The development of Hodgkin's disease and lymphoma during anticonvulsant therapy.

Authors:  G A Hyman; S C Sommers
Journal:  Blood       Date:  1966-09       Impact factor: 22.113

8.  Hydantoin-induced pseudo-pseudolymphoma.

Authors:  R A Gams; J A Neal; F G Conrad
Journal:  Ann Intern Med       Date:  1968-09       Impact factor: 25.391

9.  Lymphocytotoxins in primary renal disease.

Authors:  B S Ooi; A R Orlina; L Masaitis
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

10.  Lymphocytotoxins and pernicious anemia.

Authors:  L S Goldberg; J E Cunningham; P I Terasaki
Journal:  Blood       Date:  1972-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.